Banner Image

Test Directory

MPL Mutation Analysis

Test Summary

This DNA-based assay tests leukocytes from blood or bone marrow aspirate for mutations in exon 10 of the thrombopoietin receptor (MPL), including codons 505 and 515, using an advanced DNA sequencing method. Mutations at these sites in MPL are associated with myeloproliferative neoplasms, particularly essential thrombocythemia and primary myelofibrosis.

Aliases

  • N/A

Specimen Collection

Special Instructions

N/A

Preferred Specimen

4 mL whole blood or 3 mL bone marrow aspirate collected in an EDTA (lavender-top) tube

Minimum Volume

3 mL whole blood • 1 mL bone marrow aspirate

Instructions

Note: Do not reject specimens, send to lab for screening.

Cell Pellets: Send fixed samples within 7 days of fixation date in a plastic, leak-proof tube/container. Indicate type of fixative used along with patient name, specimen source, date collected, and date harvested/fixed. Cell pellets submitted in Carnoy's or other alcohol-based fixatives are acceptable.

Patient Preparation

N/A

Storage

N/A

Transport Temperature

Room temperature

Specimen Stability

  • Whole blood, Bone marrow aspirate, Fixed cell pellets
  • Room temperature: 7 days
  • Refrigerated: 7 days
  • Frozen: Unacceptable
  • Extracted DNA
  • Room temperature:7 days
  • Refrigerated: 1

Limitations

N/A

Other Acceptable Specimens

Whole blood or bone marrow aspirate collected in a sodium heparin (green-top) tube • Fixed Cell pellet collected in a plastic leak-proof container • Extracted DNA from CLIA-certified laboratory collected in a sterile leak-proof container

Unacceptable Specimens

N/A

Order Code

MPLMUT

EPIC (Premier) Code

LAB6124

Includes

N/A

CPT Code

  • 81339

Billing Code

  • 670857

CPT Statement

Methodology

Polymerase Chain Reaction-based DNA Sequencing

FDA Status

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Physician Attestation of Informed Consent

N/A

Testing Laboratory

Quest Diagnostics Nichols Institute
14225 Newbrook Drive
Chantilly VA, 20153

Department

Reference Testing

Reference Range

See Laboratory Report

Setup Schedule / Expected Turnaround Time

Daily; Report available: 5 - 7 days

Specimen Collection

Special Instructions

N/A

Preferred Specimen

4 mL whole blood or 3 mL bone marrow aspirate collected in an EDTA (lavender-top) tube

Minimum Volume

3 mL whole blood • 1 mL bone marrow aspirate

Instructions

Note: Do not reject specimens, send to lab for screening.

Cell Pellets: Send fixed samples within 7 days of fixation date in a plastic, leak-proof tube/container. Indicate type of fixative used along with patient name, specimen source, date collected, and date harvested/fixed. Cell pellets submitted in Carnoy's or other alcohol-based fixatives are acceptable.

Patient Preparation

N/A

Storage

N/A

Transport Temperature

Room temperature

Specimen Stability

  • Whole blood, Bone marrow aspirate, Fixed cell pellets
  • Room temperature: 7 days
  • Refrigerated: 7 days
  • Frozen: Unacceptable
  • Extracted DNA
  • Room temperature:7 days
  • Refrigerated: 1

Limitations

N/A

Other Acceptable Specimens

Whole blood or bone marrow aspirate collected in a sodium heparin (green-top) tube • Fixed Cell pellet collected in a plastic leak-proof container • Extracted DNA from CLIA-certified laboratory collected in a sterile leak-proof container

Unacceptable Specimens

N/A

Billing

CPT Code

  • 81339

Billing Code

  • 670857

CPT Statement

Result Information

Methodology

Polymerase Chain Reaction-based DNA Sequencing

Testing Laboratory

N/A

Reference Range

See Laboratory Report

Setup Schedule / Expected Turnaround Time

Daily; Report available: 5 - 7 days